VENUSREMNSEVenus Remedies Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 20 Nov, 2025 · 10:32 IST

Significant increase in volume has been observed in Venus Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Venus Remedies Limited has submitted their response.

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.3%Reaction day
₹652.00
prior close
₹683.75
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+6.6% vs market
Pharmaceuticals peers, median of 156sector-0.1%+6.4% vs sector

On the reaction day the stock moved 6.6 pts more than Nifty Microcap 250 and 6.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.2
15m
-0.3
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+6.3-0.3+6.6-0.1+6.4
Next day
+8.0-1.8+9.8-0.8+8.8
2d
+9.7-2.4+12.1-1.8+11.5
3d
+3.9-2.3+6.2-1.9+5.8
4d
+7.2-1.0+8.2-0.8+8.0
5d
+10.1-1.5+11.6-1.0+11.1
1w
+12.7-1.7+14.5-1.1+13.8
15d
+28.1-5.0+33.1-3.4+31.4
1m
+23.5-3.6+27.1-2.2+25.7
2m
+10.8-11.3+22.1-7.8+18.6
3m
+16.7-7.7+24.4-10.1+26.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE noticed an unusual spike in trading volume for Venus Remedies and wrote to the company seeking clarification. The company has submitted its response to the exchange, though the details of the response are not included in this filing. Such volume surveillance alerts are routine and triggered whenever a stock sees sharp, unexplained price or volume moves that could signal undisclosed information.

Likely market impact

This is an exchange-level surveillance step rather than a regulatory action against the company. Investors should watch for any clarification from Venus Remedies or any follow-up filing explaining the volume spike, but no immediate negative implication should be assumed unless further action is announced.